Tuesday, January 14, 2020

Attentional Control Challenges - Relief - Wild - Dreyfus - 2020

Two Americans report substantial relief:

- C. Thomas Wild - Inattentive ADHD - due to Tirend, a FDA approved alertness aid medicine containing caffeine and other ingredients.

- Jack Dreyfus - Epilepsy - due to Dilantin, a FDA approved anti-epilepsy medicine.


No comments:

Post a Comment